retatrutide triple hormone receptor agonist weight loss Medscape | Retatrutide, Eli Lilly's first-in-class agonist, delivered meaningful at 80 weeks in all doses in the Triple Agonism Based Therapies for
Pay in 4 interest-free payments of $7.23 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18


























